Marino Stram & Associates’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$478K Sell
6,113
-261
-4% -$21.1K 0.08% 126
2026
Q1
$552K Sell
6,374
-486
-7% -$46.6K 0.1% 108
2025
Q4
$659K Buy
6,860
+9
+0.1% +$874 0.12% 106
2025
Q3
$652K Sell
6,851
-282
-4% -$25.9K 0.12% 109
2025
Q2
$622K Sell
7,133
-272
-4% -$23.1K 0.13% 105
2025
Q1
$665K Sell
7,405
-14
-0.2% -$1.25K 0.15% 100
2024
Q4
$593K Buy
7,419
+534
+8% +$46.2K 0.13% 105
2024
Q3
$620K Buy
6,885
+24
+0.3% +$2.02K 0.14% 104
2024
Q2
$540K Sell
6,861
-275
-4% -$22.5K 0.13% 104
2024
Q1
$622K Buy
7,136
+9
+0.1% +$768 0.15% 100
2023
Q4
$587K Buy
7,127
+126
+2% +$9.6K 0.15% 98
2023
Q3
$549K Buy
7,001
+2,865
+69% +$240K 0.16% 94
2023
Q2
$364K Buy
4,136
+171
+4% +$14.7K 0.1% 115
2023
Q1
$320K Buy
3,965
+577
+17% +$47K 0.1% 121
2022
Q4
$263K Buy
3,388
+242
+8% +$19.6K 0.08% 128
2022
Q3
$254K Buy
3,146
+540
+21% +$48.5K 0.09% 121
2022
Q2
$234K Buy
2,606
+1
+0% +$101 0.08% 131
2022
Q1
$289K Buy
+2,605
New +$275K 0.09% 127
2021
Q3
Sell
-2,983
Closed -$370K 229
2021
Q2
$370K Buy
+2,983
New +$375K 0.1% 165
2019
Q2
Sell
-227
Closed -$21K 373
2019
Q1
$21K Sell
227
-31
-12% -$2.77K 0.02% 239
2018
Q4
$23K Hold
258
0.02% 200
2018
Q3
$25K Buy
258
+24
+10% +$2.22K 0.02% 225
2018
Q2
$20K Sell
234
-192
-45% -$16K 0.02% 244
2018
Q1
$34K Hold
426
0.03% 195
2017
Q4
$34K Buy
+426
New +$34.1K 0.03% 199

Other funds holding MDT

Marino Stram & Associates's MDT Position: Q2 2026 in Review

Marino Stram & Associates reduced its Medtronic (MDT) stake by 4.1% in Q2 2026, selling an estimated $21.1K and leaving 6,113 shares worth $478K. The position accounts for 0.08% of the portfolio, ranked #126.

Marino Stram & Associates first reported a position in MDT in Q4 2017 and has held it in 25 quarters since. The position peaked at $665K in Q1 2025. 959 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Marino Stram & Associates held 6,113 shares of Medtronic worth $478K as of Q2 2026.
  • Marino Stram & Associates sold 261 Medtronic shares in Q2 2026, an estimated $21.1K.
  • Medtronic made up 0.08% of Marino Stram & Associates's portfolio in Q2 2026, its #126 holding.
  • Marino Stram & Associates first reported a position in Medtronic in Q4 2017 and has held it in 25 quarters since.
  • Marino Stram & Associates's Medtronic position peaked at $665K in Q1 2025.
  • 959 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Marino Stram & Associates's 13F filing for Q2 2026, filed 24 Jul 2026.